Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Tenet Healthcare
THC
$22.6B
| $100M | 0.06% |
1,506,871
+15,900
| +1% | +$1.13M |
|
|
CTLT
302
DELISTED
CATALENT, INC.
CTLT
| $99.6M | 0.06% |
748,640
-230,970
| -24% | -$28.8M |
|
303
Thermo Fisher Scientific
TMO
$233B
| $98.7M | 0.06% |
172,755
-34,331
| -17% | -$18.8M |
|
304
PUT
SLB Ltd
SLB
$79.9B
| $98.2M | 0.06% |
3,313,600
+1,506,200
| +83% | +$43.2M |
|
305
PUT
United Rentals
URI
$68.4B
| $97.5M | 0.06% |
277,800
+205,600
| +285% | +$69M |
|
306
Snap
SNAP
$8.86B
| $97.3M | 0.06% |
1,316,735
-148,685
| -10% | -$10.7M |
|
307
Vulcan Materials
VMC
$35.8B
| $97.2M | 0.06% |
574,868
+160,621
| +39% | +$28.8M |
|
308
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.4B
| $97.1M | 0.06% |
1,081,726
+913,086
| +541% | +$82.9M |
|
|
DAY
309
CALL
DELISTED
Dayforce
DAY
| $96.9M | 0.06% |
+860,000
| New | +$90.3M |
|
|
CVA
310
DELISTED
Covanta Holding Corporation
CVA
| $96.8M | 0.06% |
4,812,071
+4,689,402
| +3,823% | +$92.7M |
|
311
Evercore
EVR
$11.2B
| $96.6M | 0.06% |
722,552
+354,082
| +96% | +$48.1M |
|
|
MDLA
312
DELISTED
Medallia, Inc.
MDLA
| $96.1M | 0.06% |
2,836,097
+2,720,801
| +2,360% | +$90.8M |
|
313
Danaher
DHR
$154B
| $95.9M | 0.06% |
355,202
-256,590
| -42% | -$69.9M |
|
314
Nokia
NOK
$57B
| $95.4M | 0.06% |
17,511,352
-2,827,944
| -14% | -$16.4M |
|
315
Diamondback Energy
FANG
$59B
| $95.4M | 0.06% |
1,007,415
+763,161
| +312% | +$61.3M |
|
316
KLA
KLAC
$240B
| $95.1M | 0.06% |
2,843,540
-170,130
| -6% | -$5.68M |
|
317
Intuit
INTU
$100B
| $95.1M | 0.06% |
176,290
+94,524
| +116% | +$50.9M |
|
318
PUT
Pembina Pipeline
PBA
$28.3B
| $95M | 0.06% |
+2,365,000
| New | +$74.6M |
|
319
PUT
Moderna
MRNA
$57.9B
| $94.9M | 0.06% |
246,600
+76,600
| +45% | +$28.3M |
|
320
CALL
Lyft
LYFT
$6.61B
| $94.5M | 0.06% |
1,762,800
+620,000
| +54% | +$32.9M |
|
321
WEC Energy
WEC
$34.5B
| $94.5M | 0.06% |
1,070,862
-673,229
| -39% | -$63.1M |
|
322
General Motors
GM
$77.2B
| $94.4M | 0.06% |
1,791,336
+656,958
| +58% | +$34.9M |
|
323
NXP Semiconductors
NXPI
$56.9B
| $94.3M | 0.06% |
481,377
+414,288
| +618% | +$86M |
|
324
IQVIA
IQV
$42.8B
| $94.1M | 0.06% |
392,723
-38,918
| -9% | -$9.82M |
|
325
CALL
Lowe's Companies
LOW
$121B
| $94.1M | 0.06% |
463,700
+136,500
| +42% | +$27.2M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.